rs138231868
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1
This summary comes from the ClinGen Evidence Repository: This is a missense variant in SCN1A, c.4393A>G, (p.Ile1465Val). This variant is present in gnomAD at 0.04% within the total population, with the highest sub-population frequency of 0.4% within the African/African population American population (BA1). In summary, this variant meets criteria to be classified as benign for autosomal dominant dravet syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen Epilepsy Sodium Channel VCEP: BA1 (version 1.0; approved 6/13/23). LINK:https://erepo.genome.network/evrepo/ui/classification/CA295639/MONDO:0100135/067
Frequency
Consequence
NM_001165963.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN1A | ENST00000674923.1 | c.4393A>G | p.Ile1465Val | missense_variant | Exon 26 of 29 | NM_001165963.4 | ENSP00000501589.1 | |||
SCN1A | ENST00000303395.9 | c.4393A>G | p.Ile1465Val | missense_variant | Exon 25 of 28 | 5 | ENSP00000303540.4 | |||
SCN1A | ENST00000375405.7 | c.4360A>G | p.Ile1454Val | missense_variant | Exon 23 of 26 | 5 | ENSP00000364554.3 | |||
SCN1A | ENST00000409050.1 | c.4309A>G | p.Ile1437Val | missense_variant | Exon 23 of 26 | 5 | ENSP00000386312.1 |
Frequencies
GnomAD3 genomes AF: 0.00111 AC: 167AN: 151022Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000273 AC: 68AN: 249444Hom.: 0 AF XY: 0.000222 AC XY: 30AN XY: 134928
GnomAD4 exome AF: 0.000113 AC: 164AN: 1454830Hom.: 0 Cov.: 29 AF XY: 0.0000967 AC XY: 70AN XY: 723888
GnomAD4 genome AF: 0.00110 AC: 167AN: 151140Hom.: 0 Cov.: 32 AF XY: 0.00110 AC XY: 81AN XY: 73816
ClinVar
Submissions by phenotype
not specified Benign:3
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
- -
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Early infantile epileptic encephalopathy with suppression bursts Benign:1
- -
not provided Benign:1
- -
Severe myoclonic epilepsy in infancy Benign:1
This is a missense variant in SCN1A, c.4393A>G, (p.Ile1465Val). This variant is present in gnomAD at 0.04% within the total population, with the highest sub-population frequency of 0.4% within the African/African population American population (BA1). In summary, this variant meets criteria to be classified as benign for autosomal dominant dravet syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen Epilepsy Sodium Channel VCEP: BA1 (version 1.0; approved 6/13/23). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at